|
|
||||||||
Neurology, Vol 45, Issue 11 1985-1990, Copyright © 1995 by American Academy of Neurology
ARTICLES |
M Gearing, JA Schneider, GW Rebeck, BT Hyman and SS Mirra
Veterans Affairs Medical Center, Atlanta, GA, USA.
The frequency of the apolipoprotein E (ApoE) epsilon 4 allele and its relationship with coexistent Parkinson's disease (PD) neuropathology in Alzheimer's disease (AD) have not been extensively explored. We determined ApoE genotype in 100 dementia patients with neuropathologically confirmed AD with and without concomitant Parkinson's disease (PD) changes (nigral degeneration and Lewy bodies at various sites). Fifty "AD+PD" patients were matched closely with 50 "pure AD" patients for age, sex, and duration of dementia. We found identical overrepresentation of the epsilon 4 allele in the two groups: 72% of the patients in each group had at least one ApoE epsilon 4 allele, compared with approximately 25% in the general population (p < 0.005) and in our institutional autopsy population (p < 0.001). Age at onset varied inversely with epsilon 4 allele dosage in men but not in women in both the AD and the AD+PD groups. As with amyloid deposition and plaque frequency in AD, we observed an association between epsilon 4 dosage and PD-related changes. Specifically, the severity of ubiquitin-positive neuritic change in CA2/3 of the hippocampus, but not the frequency of cortical Lewy bodies, varied significantly with epsilon 4 dosage in the AD+PD cases.
This article has been cited by other articles:
![]() |
J. Choi, H. D. Rees, S. T. Weintraub, A. I. Levey, L.-S. Chin, and L. Li Oxidative Modifications and Aggregation of Cu,Zn-Superoxide Dismutase Associated with Alzheimer and Parkinson Diseases J. Biol. Chem., March 25, 2005; 280(12): 11648 - 11655. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Tsuang, R. K. Wilson, O. L. Lopez, E. K. Luedecking-Zimmer, J. B. Leverenz, S. T. DeKosky, M. I. Kamboh, and R. L. Hamilton Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease Neurology, February 8, 2005; 64(3): 509 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Choi, A. I. Levey, S. T. Weintraub, H. D. Rees, M. Gearing, L.-S. Chin, and L. Li Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases J. Biol. Chem., March 26, 2004; 279(13): 13256 - 13264. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Leverenz, C. M. Agustin, D. Tsuang, E. R. Peskind, S. D. Edland, D. Nochlin, L. DiGiacomo, J. D. Bowen, W. C. McCormick, L. Teri, et al. Clinical and Neuropathological Characteristics of Hippocampal Sclerosis: A Community-Based Study Arch Neurol, July 1, 2002; 59(7): 1099 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chapman, A. D. Korczyn, D. M. Karussis, and D. M. Michaelson The effects of APOE genotype on age at onset and progression of neurodegenerative diseases Neurology, October 23, 2001; 57(8): 1482 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tsuang, E. B. Larson, J. Bowen, W. McCormick, L. Teri, D. Nochlin, J. B. Leverenz, E. R. Peskind, A. Lim, M. A. Raskind, et al. The Utility of Apolipoprotein E Genotyping in the Diagnosis of Alzheimer Disease in a Community-Based Case Series Arch Neurol, December 1, 1999; 56(12): 1489 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Green and A. I. Levey Event-Related Potential Changes in Groups at Increased Risk for Alzheimer Disease Arch Neurol, November 1, 1999; 56(11): 1398 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
L A Hansen, S E Daniel, G K Wilcock, and S Love Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia J. Neurol. Neurosurg. Psychiatry, May 1, 1998; 64(5): 653 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Berg, D. W. McKeel Jr, J. P. Miller, M. Storandt, E. H. Rubin, J. C. Morris, J. Baty, M. Coats, J. Norton, A. M. Goate, et al. Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype Arch Neurol, March 1, 1998; 55(3): 326 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Beal and J.-P. Vonsattel Case 7-1998- A 74-Year-Old Man with Dementia, Parkinsonism, and an Insular Lesion N. Engl. J. Med., February 26, 1998; 338(9): 603 - 610. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |